When the AD group was divided into the T1D and LADA subgroups, we observed significantly higher IL-15 and IL-6 concentrations (p < 0.001) and significantly lower IA-2A levels (p = 0.01) in the patients with LADA as compared to the T1D group (Table 2). The gene discussed is IL15; the disease is Alzheimer disease.